Trial intelligence / Profile preview

Afentanil use in pediatric bronchoscopy with spontaneous breathing

ChiCTR2200066130Phase 4Recruiting

Sponsor
Shenzhen Children's Hospital
Start
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of alfentanil in pneumonia (3 arms), sponsored by Shenzhen Children's Hospital. Primary endpoint: Frequency of coughing episodes during the examination. Started Jan 2022; status: recruiting.

02

Drugs

alfentanil
03

Conditions

pneumonia

Beyond the preview

Go deeper on ChiCTR2200066130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200066130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call